![](/img/cover-not-exists.png)
A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves’ disease
McLachlan, Sandra M., Rapoport, BasilLanguage:
english
Journal:
Endocrine
DOI:
10.1007/s12020-019-02083-9
Date:
September, 2019
File:
PDF, 1009 KB
english, 2019